Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-08-14 | 2018-09-05 | 58073 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-14 | 2017-04-18 | 2304 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-05-09 | 2017-11-22 | 9705 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-01-16 | 2019-03-05 | 72434 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-03-08 | 2019-04-17 | 78081 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |